Company profile for Eterna Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eterna Therapeutics is developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. We and our strategic partners are advancing innovative nucleic acid and cell therapies that offer the hope of radically improving the health outcomes of patients with high unmet medical needs. We are committed to creating a world in which patients and their families have...
Eterna Therapeutics is developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. We and our strategic partners are advancing innovative nucleic acid and cell therapies that offer the hope of radically improving the health outcomes of patients with high unmet medical needs. We are committed to creating a world in which patients and their families have access to effective, life-changing treatments for serious illnesses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1035 Cambridge Street Suite 18A Cambridge, MA 02141
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/03/25/3048736/0/en/Eterna-Therapeutics-Changes-Name-to-Ernexa-Therapeutics-to-Reflect-New-Strategic-Focus-on-Ovarian-Cancer-and-Autoimmune-Disease.html

GLOBENEWSWIRE
25 Mar 2025

https://www.globenewswire.com/news-release/2025/02/26/3032931/0/en/Eterna-Therapeutics-Hosts-Successful-Inaugural-Meeting-with-Newly-Formed-Scientific-Advisory-Board-to-Advance-Cell-Therapy-Pipeline.html

GLOBENEWSWIRE
26 Feb 2025

https://www.globenewswire.com/news-release/2025/01/28/3016398/0/en/Eterna-Therapeutics-Announces-Expansion-of-Scientific-Advisory-Board.html

GLOBENEWSWIRE
28 Jan 2025

https://www.globenewswire.com/news-release/2025/01/14/3009318/0/en/Eterna-Therapeutics-Announces-Positive-Preclinical-Study-Results-on-Lead-Product-ERNA-101-in-Ovarian-Cancer.html

GLOBENEWSWIRE
14 Jan 2025

https://www.globenewswire.com/news-release/2025/01/09/3006981/0/en/Eterna-Therapeutics-Announces-Appointment-of-Dr-Elena-Ratner-to-Board-of-Directors.html

GLOBENEWSWIRE
09 Jan 2025

https://www.globenewswire.com/news-release/2024/12/03/2990647/0/en/Eterna-Therapeutics-Launches-Research-to-Evaluate-its-Lead-Induced-Mesenchymal-Stem-Cell-Therapy-Candidate-s-ERNA-101-Ability-to-Induce-and-Modulate-Antitumor-Immunity-in-Ovarian-C.html

GLOBENEWSWIRE
03 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty